SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sarepta Therapeutics, Inc. – ‘8-K’ for 6/2/22 – ‘EXCEL’

On:  Friday, 6/3/22, at 4:20pm ET   ·   For:  6/2/22   ·   Accession #:  950170-22-11164   ·   File #:  1-14895

Previous ‘8-K’:  ‘8-K’ on 4/21/22 for 4/19/22   ·   Next:  ‘8-K’ on 9/19/22 for 9/13/22   ·   Latest:  ‘8-K’ on / for 1/8/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/03/22  Sarepta Therapeutics, Inc.        8-K:5,9     6/02/22   11:250K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     49K 
 2: EX-10.1     Material Contract                                   HTML     11K 
 6: R1          Document And Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- srpt-20220602_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.LAB  XBRL Labels -- srpt-20220602_lab                     XML     40K 
 4: EX-101.PRE  XBRL Presentations -- srpt-20220602_pre              XML     31K 
 3: EX-101.SCH  XBRL Schema -- srpt-20220602                         XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-011164-xbrl      Zip     13K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 2/28/24  Sarepta Therapeutics, Inc.        10-K       12/31/23  119:18M                                    Donnelley … Solutions/FA
 8/02/23  Sarepta Therapeutics, Inc.        S-8         8/02/23    4:69K                                    Donnelley … Solutions/FA
 2/28/23  Sarepta Therapeutics, Inc.        10-K       12/31/22  119:23M                                    Donnelley … Solutions/FA
 8/02/22  Sarepta Therapeutics, Inc.        S-8         8/02/22    4:58K                                    Donnelley … Solutions/FA
 8/02/22  Sarepta Therapeutics, Inc.        10-Q        6/30/22   79:11M                                    Donnelley … Solutions/FA
Top
Filing Submission 0000950170-22-011164   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 5:44:27.2pm ET